ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Pharma R&D Business Models Under Pressure To Improve Efficiency
Read this article to learn how to improve the efficiency of trial designs & procedures throughout the drug development process.
Ten Developments to Watch Out For in Life Sciences
Discover the top digital & tech developments in the life science industry, including mHealth, AI, robotic process automation, and more.
Optimizing Study Design in Real-World Evidence Generation
Discover the importance of specialist epidemiology knowledge, due to their specialised focus on pharmacoepidemiological study design, to ensure robust and reliable downstream study findings.
Innovation In Epidemiological Research
An article written by Kerina Bonar & Rob Sambrook, exploring opportunities for pairing hybrid study design with epidemiological expertise for RWE generation.
Connecting With The Patient
E.B. McLindon explains how ICON is taking a different approach with its Integrated Site Network in this Scrip 100 media article.
A Look at Cost Challenges of Precision Medicine & Rare Disease
The cost challenges presented by precision medicine in rare disease, and the strategies that can be employed to overcome them.
An "Icon" in Clinical Research
An article discussing ICON's unmatched global reach & expertise in oncology & work with Pfizer.
ACT NOW – Cancer Trials At The Leading Edge
A thought leadership article by Martin Lachs, Olivier Saulin and Chris Learn on how CROs can best support increasing demand for ACT clinical trials.
Icon non-executive chairman awarded RDS gold medal for outstanding leadership
An article featuring commentary from Ciarán Murray on his achievement of being awarded with the RDS gold medal for enterprise for outstanding leadership.
Ciarán Murray – an Icon of leadership in pharma sector
An article featuring commentary from Ciarán Murray on the growth of ICON and his career journey to achieve the RDS Gold Medal for Industry.